Upstream Bio

About:

Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma.

Website: https://www.upstreambio.com

Twitter/X: UpstreamBio

Top Investors: OrbiMed, Enavate Sciences, Samsara BioCapital, Wellington Management, Bain Capital Life Sciences

Description:

Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma. They are clinical-stage monoclonal antibodies that inhibit the TSLP receptor, a validated target located upstream of various signaling cascades that influence a range of immune cells that are important in common and unusual illnesses.